BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37732511)

  • 21. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
    Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
    Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma.
    Chen J; Yu Y; Ji T; Ma R; Chen M; Li G; Li F; Ding Q; Kang Q; Huang D; Liang X; Lin H; Cai X
    Cancer Med; 2016 Oct; 5(10):2678-2687. PubMed ID: 27650414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection.
    Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F
    J Virol; 2020 May; 94(10):. PubMed ID: 32161178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver expression of Nrf2-related genes in different liver diseases.
    Cheng ML; Lu YF; Chen H; Shen ZY; Liu J
    Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):485-91. PubMed ID: 26459724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S-1-propenylmercaptocysteine protects murine hepatocytes against oxidative stress via persulfidation of Keap1 and activation of Nrf2.
    Tocmo R; Parkin K
    Free Radic Biol Med; 2019 Nov; 143():164-175. PubMed ID: 31349040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
    Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanism of Tibetan medicine Ershiwuwei Songshi Pills against liver injury induced by acetaminophen in mice based on Keap1/Nrf2 and TLR4/NF-κB p65 signaling pathways].
    Sha YR; Luo XM; Ding Y; Yang B; Jian CF; Gong PY; Gu J; Tan R
    Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):2049-2055. PubMed ID: 35531720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
    Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
    J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis.
    Jin K; Shi Y; Zhang H; Zhangyuan G; Wang F; Li S; Chen C; Zhang J; Wang H; Zhang W; Sun B
    J Hepatol; 2023 Aug; 79(2):403-416. PubMed ID: 37040844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.
    Pal Chaudhary S; Reyes S; Chase ML; Govindan A; Zhao L; Luther J; Bhan I; Bethea E; Franses JW; Paige Walsh E; Anne Dageford L; Kimura S; Elias N; Yeh H; Markman J; Bozorgzadeh A; Tanabe K; Ferrone C; Zhu AX; Andersson K; Thiim M; Antonio Catalano O; Kambadakone A; Vagefi PA; Qadan M; Pratt D; Hashemi N; Corey KE; Misdraji J; Goyal L; Clark JW
    Oncologist; 2023 Apr; 28(4):341-350. PubMed ID: 36763374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress.
    Mohammed S; Nicklas EH; Thadathil N; Selvarani R; Royce GH; Kinter M; Richardson A; Deepa SS
    Free Radic Biol Med; 2021 Feb; 164():315-328. PubMed ID: 33429022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
    Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
    J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Hu X; Mu L; Zhu L; Chang X; Nie L; Wang L; Li G
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment.
    Keleku-Lukwete N; Suzuki M; Yamamoto M
    Antioxid Redox Signal; 2018 Dec; 29(17):1746-1755. PubMed ID: 28899203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear Factor Erythroid 2-Related Factor 2/Kelch-Like ECH-Associated Protein 1 as a Predictor of Prognosis and Radiotherapy Resistance in Patients With Locally Advanced Rectal Cancer: A Prospective Analysis.
    Park JM; Kim S; Bae SU; Byun SJ; Seo I; Lee HW
    J Korean Med Sci; 2023 Jul; 38(26):e200. PubMed ID: 37401495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet.
    Ganguly S; Muench GA; Shang L; Rosenthal SB; Rahman G; Wang R; Wang Y; Kwon HC; Diomino AM; Kisseleva T; Soorosh P; Hosseini M; Knight R; Schnabl B; Brenner DA; Dhar D
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):891-920. PubMed ID: 34062281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
    Haque E; Śmiech M; Łuczyńska K; Bouchard MF; Viger R; Kono H; Pierzchała M; Taniguchi H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis.
    Yang JJ; Tao H; Huang C; Li J
    Food Chem Toxicol; 2013 Sep; 59():421-7. PubMed ID: 23793039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.